title: The new drug evaluation process: risk benefit ratio.
authors.forename: John C
authors.initials: JC
authors.lastname: Somberg
mesh_terms: D017277:Drug Approval / Q000458:organization & administration*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment; D014481:United States